TC Biopharm (Holdings) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1253.7%.

Top 13 shareholders own 2.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.91%	Platform Technology Partners, LLC	5,000	€34.6k	0%	0.01%
0.44%	Bryan Kobel	2,391	€16.5k	23,800%	no data
0.41%	Citadel Advisors LLC	2,252	€15.6k	0%	no data
0.22%	Csenge Advisory Group, Llc, Asset Management Arm	1,200	€8.3k	-17.2%	no data
0.11%	SignatureFD, LLC	595	€4.1k	0%	no data
0.038%	UBS Asset Management AG	210	€1.5k	624%	no data
0.035%	Nipro Corporation	193	€1.3k	0%	no data
0.015%	Rhumbline Advisers Ltd Partnership	84	€581.0	0%	no data
0.013%	Angela Scott	74	€511.7	0%	no data
0.012%	Michael Leek	66	€456.3	0%	no data
0.00091%	Wells Fargo & Company, Securities and Brokerage Investments	5	€34.5	0%	no data
0.00018%	Headlands Technologies Llc, Asset Management Arm	1	€6.8	-88.9%	no data
0.00018%	Martin Thorp	1	€6.8	0%	no data